The role of macrophage migration inhibitory factor in the development of obesity and altered intestinal permeability
2017
Преузимање 🢃
Аутори:
Saksida, TamaraMićanović, Dragica
Koprivica, Ivan
Nikolić, Ivana
Vujičić, Milica
Stošić-Grujičić, Stanislava
Stojanović, Ivana D.
Остала ауторства
Spasojević, IvanТип документа:
Конференцијски прилог (Објављена верзија)
,
© 2017 by the Serbian Biochemical Society
Метаподаци
Приказ свих података о документуАпстракт:
Macrophage migration inhibitory factor (MIF) is a molecule expressed both by the immune
cells, like T, B lymphocytes and macrophages, and non-immune cells, like adipocytes,
hepatocytes and beta cells of pancreatic islets. It has actions in the innate and adaptive
immunity, such as a part in regulating the interleukin-17 expression and production, but also
in the development of chemically induced type 1 diabetes in mice. This paper summarizes our
results on the role of MIF in the development of obesity and type 2 diabetes, done in vitro on
beta cell models and murine pancreatic islets, as well as in vivo, when mice with MIF deletion
(MIF-KO) and their wild type (wt) counterparts were on a high fat diet. It is considered that
obesity can develop as a consequence of altered intestinal permeability, so potential leakage of
the intestinal barrier is investigated in the MIF-KO and wt mice. Also, the interplay between
MIF and regulatory T cells, as an important regulator of inflammation in the adipose tissue, is
explored at the level of visceral adipose tissue.
Финансирање / пројекти:
- Министарство науке, технолошког развоја и иновација Републике Србије, институционално финансирање - 200007 (Универзитет у Београду, Институт за биолошка истраживања 'Синиша Станковић') (RS-MESTD-inst-2020-200007)
У:
- Spasojević I, editor. Biochemistry of Control in Life and Technology: Serbian Biochemical Society Seventh Conference with International Participation. 2017 Nov 10; Belgrade, Serbia. Belgrade: Faculty of Chemistry; 2017. p. 101-7.